We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
VA
1
VR Adviser
New York
$109M
FLSM
2
Frazier Life Sciences Management
California
$81.4M
SCM
3
Suvretta Capital Management
New York
$77M
TCM
4
Tang Capital Management
California
$73.9M -$6.2M -468,268 -9%
BlackRock
5
BlackRock
New York
$60.6M +$8.32M +628,031 +20%
Millennium Management
6
Millennium Management
New York
$46.8M +$10.6M +800,443 +38%
Capital World Investors
7
Capital World Investors
California
$45.4M -$4.89M -369,004 -12%
Vanguard Group
8
Vanguard Group
Pennsylvania
$40.5M +$105K +7,901 +0.3%
SCM
9
Silverarc Capital Management
Massachusetts
$39.2M +$14.1M +1,063,740 +78%
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$36.9M +$30.2M +2,283,766 New
WP
11
Woodline Partners
California
$31M +$5.67K +428 +0%
State Street
12
State Street
Massachusetts
$30.9M +$4.45M +336,195 +21%
VPC
13
Vestal Point Capital
New York
$30.5M +$15.1M +1,140,000 +152%
KCM
14
Kynam Capital Management
New Jersey
$29.2M +$16M +1,204,783 +199%
PHP
15
Parkman Healthcare Partners
Connecticut
$28.6M +$444K +33,505 +2%
EA
16
Emerald Advisers
Pennsylvania
$21.6M -$142K -10,759 -0.8%
OCA
17
Octagon Capital Advisors
New York
$20.6M
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$18.9M +$176K +13,298 +1%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$15.3M +$204K +15,406 +2%
EMFAT
20
Emerald Mutual Fund Advisers Trust
Pennsylvania
$13.8M -$828K -62,514 -7%
Goldman Sachs
21
Goldman Sachs
New York
$13.5M -$12.8M -964,877 -54%
EC
22
Elmind Capital
New York
$12.9M +$10.6M +801,300 New
AC
23
Armistice Capital
New York
$12.9M +$10.6M +800,000 New
Barclays
24
Barclays
United Kingdom
$11.3M +$1.62M +122,669 +21%
Morgan Stanley
25
Morgan Stanley
New York
$11.3M +$1.79M +135,372 +24%